Clinical Trial Update: Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A neoadjuvant chemoradiotherapy regimen is being explored followed by sequential immunotherapy in thoracic esophageal squamous cell carcinoma, currently in Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Qiu Guoqin | Conditions: Esophageal Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION